The MDL-SHPVP will be developed and a clustered randomised controlled trial will be conducted to evaluate the effects of the MDL-SHPVP and to examine whether the effect of the MDL-SHPVP on the rate of HPV vaccine uptake 1 year after intervention is mediated by parents'/guardians' and female adolescents' HPV knowledge, attitudes and beliefs, adolescents' intention to receive HPV vaccination and vaccine acceptance among their parents/guardians.
2520 adolescents and their parents or guardians from 18 local secondary day schools will be recruited. Multicomponent interventions will be offered to the intervention schools. To build and strengthen the community capacity in health promotion, a team of volunteers will be established to raise awareness of HPV, cervical cancer and HPV vaccine. Data will be collected at baseline, 1 month and 1 year after intervention. The mixed-effects model will be used to compare the differential changes for each of the primary and secondary outcomes across time between the two groups. The project is expected to instil a more accurate understanding of HPV and HPV vaccination and support the decision to undergo vaccination.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Enrollment
1,340
A 2-hour education session with multicomponent interventions including education sessions with small group dialogues with a registered nurse and trained healthcare and lay volunteers and educational computer games
A 30-minute education video (DVD) on HPV, cervical cancer and the HPV vaccine that is designed to enhance HPV vaccine acceptance
The Chinese University of Hong Kong
Shatin, Hong Kong
Female adolescents' uptake of the HPV vaccine
Self report uptake of the HPV vaccine by the female adolescents in the past 12 months.
Time frame: 1 year post-intervention
Change of female adolescents' intention to receive HPV vaccination
A 10-point Likert scale will be used to measure the intention indicates "Definitely". 1 indicates "Definitely not" and 10 indicates "Definitely". Higher value means higher intention.
Time frame: baseline, 1 month post-intervention
Change of vaccine acceptance among parents/guardians
Precaution Adoption Process Model will be used to measure the vaccine acceptance.
Time frame: baseline, 1 month post-intervention
Change of female adolescents' and parents'/ guardians' HPV knowledge
HPV General and HPV Vaccine Knowledge Scale will be used to measure the knowledge.1 point will be given to each correct answer and 0 points will be given to each incorrect or "Don't know" answer. Higher scores mean more HPV knowledge.
Time frame: baseline, 1 month post-intervention
Change of female adolescents' HPV attitudes and beliefs
Carolina HPV Immunisation Attitudes and Beliefs Scale will be used to measure the attitudes and belief. An 11-point Likert scale will be used, with 0, 5, 7 and 10 indicate "strongly disagree," "somewhat disagree," "somewhat agree" and "strongly agree" respectively, or indicate "extremely ineffective, "somewhat ineffective," "somewhat effective" and "extremely effective" respectively. Higher values mean stronger agreement with the statement and less agreement with or endorsement of HPV vaccination. Five items will be reverse-coded.
Time frame: baseline, 1 month post-intervention
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Change of parents'/ guardians' HPV attitudes and beliefs
Carolina HPV Immunisation Attitudes and Beliefs Scale will be used to measure the attitudes and belief. A 4-point Likert scale will be used. 1,2,3 and 4 indicate "strongly disagree," "somewhat disagree," somewhat agree," and "strongly agree" respectively. Higher values indicate stronger agreement with the statement.
Time frame: baseline, 1 month post-intervention